Can software make spinal cord stimulation setup easier for chronic pain?
NCT ID NCT06057480
First seen Sep 25, 2026 ยท Last updated Sep 25, 2026
Summary
Researchers are testing an assisted programming module for the Evoke spinal cord stimulation system in people with chronic pain of the trunk or limbs. The study enrolls about 30 participants who have or plan to have a temporary Evoke trial. The goal is to see whether the module can generate a closed-loop stimulation program and how long that takes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Evoke spinal cord stimulation system with an assisted programming module
- What this could lead to
- If it works, the assisted programming module could make spinal cord stimulation setup faster and easier for people with chronic pain.
- What could go wrong
- This is a small, single-arm study with no comparison group, so it cannot prove the module works better than standard programming. Results may not apply to all patients or pain types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Sep 2023
- Finished
-
Dec 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subject has or is planning to undergo a temporary trial with Evoke System within the FDA approved indication. * Subject is willing and capable of giving informed consent and able to comply with study-related requirements. Exclusion Criteria: * There are no exclusion criteria.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic pain are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Clinical Research
Winston-Salem, North Carolina, 27103, United States
-
Pacific Research Institute
Santa Rosa, California, 95403, United States
-
The Orthopaedic Institute, PA
Gainesville, Florida, 32607, United States
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain's insula targeted in experimental pain trial
- Can a steroid shot stop nerve pain after back pain treatment?
- Can reconnecting nerves during breast surgery restore feeling and reduce pain?
- Can a smartphone app help tame chronic pain?
- Can a gel injection into spinal discs relieve chronic neck pain?
- One 2-Hour class may help new mothers manage Post-Cesarean pain